M28 Capital Management

Latest statistics and disclosures from M28 Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are WVE, IVVD, TGTX, ARWR, GUTS, and represent 93.43% of M28 Capital Management's stock portfolio.
  • M28 Capital Management has $47M in assets under management (AUM), dropping by -12.35%.
  • Central Index Key (CIK): 0001807489

Tip: Access up to 7 years of quarterly data

Positions held by M28 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for M28 Capital Management

M28 Capital Management holds 9 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Wave Life Sciences SHS (WVE) 56.5 $27M 4.6M 5.81
 View chart
Adagio Therapeutics (IVVD) 17.1 $8.1M 9.2M 0.87
 View chart
Tg Therapeutics (TGTX) 10.3 $4.9M 88k 54.94
 View chart
Arrowhead Pharmaceuticals (ARWR) 6.4 $3.0M 37k 81.51
 View chart
Fractyl Health (GUTS) 3.1 $1.5M 1.9M 0.79
 View chart
Proqr Thrapeutics N V Shs Euro (PRQR) 2.4 $1.1M 600k 1.86
 View chart
Silence Therapeutics Ads (SLN) 2.4 $1.1M 101k 10.98
 View chart
Rocket Pharmaceuticals (RCKT) 1.5 $721k 211k 3.42
 View chart
Curis (CRIS) 0.3 $149k 285k 0.52
 View chart

Past Filings by M28 Capital Management

SEC 13F filings are viewable for M28 Capital Management going back to 2021

View all past filings